MET and hepatocellular carcinoma: The enhanced expression of c-Met protein has been observed in various tumors such as breast cancer [13], lung cancer [14], gastric cancer [15], colorectal cancer [16], cervix cancer [17], or hepatocellular carcinoma [18].